University Briefs

Cambridge researchers say they aren’t worried about last month’s City Council ordinance, which regulates the treatment of vertebrates used in laboratory experiments. According to Dick Taylor, professor of biology and chairman of the Animal Care Committee at Harvard University, the newlaw won’t affect the way research is conducted. The research laboratories in Cambridge already have very high standards, and, he says, “we’re very proud of how we care for the animals.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Cambridge researchers say they aren’t worried about last month’s City Council ordinance, which regulates the treatment of vertebrates used in laboratory experiments. According to Dick Taylor, professor of biology and chairman of the Animal Care Committee at Harvard University, the newlaw won’t affect the way research is conducted. The research laboratories in Cambridge already have very high standards, and, he says, “we’re very proud of how we care for the animals.” Taylor adds that the ordinance will actually benefit the research community by gaining the “trust and confidence of the public.”

According to Mayor Alfred E. Vellucci, who proposed the ordinance three years ago, Cambridge has set a precedent by passing the first such local law in the country. And Ken Russell, associate director of the Cambridge Committee for Responsible Research, says he has had requests for information about the ordinance from the city of Lowell, Mass., and from cities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies